/
© 2026 RiffOn. All rights reserved.

Get your free personalized podcast brief

We scan new podcasts and send you the top 5 insights daily.

  1. The BioHub - by Avetix
  2. Episode 212 - Luis Pena - Founder & CEO Evommune
Episode 212 - Luis Pena - Founder & CEO Evommune

Episode 212 - Luis Pena - Founder & CEO Evommune

The BioHub - by Avetix · Aug 6, 2026

Evommune CEO Luis Pena on the startup mindset: courage, portfolio discipline, and a resilient culture are key to navigating biotech's challenges.

Biotech Founders Must Shift from 'Pushing Buttons' in Big Pharma to 'Being the Buttons' Themselves

In large corporations, systems and departments can be activated to solve problems. In a startup, founders must possess the courage and skills to solve problems themselves, as there are no established support systems to fall back on. You become the entire mechanism.

Episode 212 - Luis Pena - Founder & CEO Evommune thumbnail

Episode 212 - Luis Pena - Founder & CEO Evommune

The BioHub - by Avetix·3 days ago

Evommune CEO's Three Hiring Rules: Be Easy to Work With, Possess Real Skills, and Work Hard

The CEO of Evommune prioritizes three non-negotiable traits when hiring: strong interpersonal skills, proven expertise without title inflation, and a robust work ethic. These are crucial because there are no support systems or places to hide in a small, high-stakes environment.

Episode 212 - Luis Pena - Founder & CEO Evommune thumbnail

Episode 212 - Luis Pena - Founder & CEO Evommune

The BioHub - by Avetix·3 days ago

Biotech CEOs Need Coaches for Mental Health, Not Just Business Strategy

The Evommune CEO reveals the most surprising aspect of his role is the extreme stress. He employs an executive coach not for business advice, but specifically to manage his mental health and maintain balance, viewing this as essential for effective leadership in a high-failure industry.

Episode 212 - Luis Pena - Founder & CEO Evommune thumbnail

Episode 212 - Luis Pena - Founder & CEO Evommune

The BioHub - by Avetix·3 days ago

Biotech Survival Depends on a Portfolio Mindset: Assume 90% of Programs Will Fail

Since most biotech programs fail (as few as 1 in 10 succeed), a company's survival depends on running a portfolio of multiple programs simultaneously. This requires the discipline to quickly terminate unsuccessful projects and the foresight to have subsequent programs already underway.

Episode 212 - Luis Pena - Founder & CEO Evommune thumbnail

Episode 212 - Luis Pena - Founder & CEO Evommune

The BioHub - by Avetix·3 days ago

Treat Investor 'Chatter' as Your Personal AI for Market Intelligence

Successful founders treat investors as more than just a source of capital. They actively listen to investor 'chatter' to gain insights on competitors, commercial viability, and market trends. This feedback loop acts as a form of human-powered AI, helping to continuously learn and make key business adjustments.

Episode 212 - Luis Pena - Founder & CEO Evommune thumbnail

Episode 212 - Luis Pena - Founder & CEO Evommune

The BioHub - by Avetix·3 days ago